Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BURNING ROCK BIOTECH LIMITED

(BNR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Burning Rock Biotech : Dx Honored with 2018 Guangzhou Hi-tech “Unicorn” and “High-grade, Precision and Advanced” Startup

09/14/2021 | 04:12am EST
Burning Rock Dx Honored with 2018 Guangzhou Hi-tech 'Unicorn' and 'High-grade, Precision and Advanced' Startup Var Date:2019-08-25

2018 Awarding Ceremony and 2019 Initiation Ceremony for Discovering Hi-tech Unicorns in Guangzhou and the Third General Assembly of the Seventh Board of Guangzhou Science and Technology Innovation Enterprises' Association (GSTIEA) was successfully hosted in Guangzhou on the afternoon of June 14, 2019. Burning Rock Biotech (GuangZhou) Co., limited (hereinafter referred to as Burning Rock) and other firms were rated as 2018 hi-tech unicorns in Guangzhou. Besides, Burning Rock was also included into the top ten Guangzhou 'high-grade, precision and advanced' startup rankings. On behalf of Burning Rock, Ms. Zhou Dan, Vice President of Business Unit of Early Cancer Screening, received the awards.

* Hi-tech unicorn: founded less than a decade ago, such firms have accessed private investment but not yet gone public, which are highly creative and fast-growing with great potential for future development (market value: ≥USD 1 billion)

* 'High-grade, precision and advanced' startup: such firms have state-of-the-art techniques or products in China or around the world and take a leading position in the industry with some industrial influence

Ms. Zhou Dan (the 5th Figure from the Left) Awarded on Behalf of Burning Rock

The hi-tech firm program titled 'Discovering Guangzhou's Unicorns' has been implemented for three consecutive years. Aimed at exploring Guangzhou's creative and fast-growing hi-tech unicorns with great development potential in such emerging industries as information technology, IoT, AI, new energy, biopharmaceutical, and big data, the program makes such hi-tech unicorns play a leading part in industrial innovation as future innovation leaders, have access to innovation resources and thoroughly blend into the world's innovation and entrepreneurship wave while offering helpful reference for government sectors in formulating favorable policies for outstanding firms by category.

Based on the two prior rankings, the program has been put in the limelight and favored by the People's Government of Guangzhou Municipality and hundreds of high-growth enterprises in Guangzhou, among which, Burning Rock stands out.

'We'd like to express my gratitude to Guangzhou Municipal Science and Technology Bureau and Guangzhou Science and Technology Innovation Enterprises' Association (GSTIEA) among other units for their full approval of Burning Rock. We founded our team over 5 years ago. Besides, we appreciate Guangzhou's institutional innovation and inclusiveness to us when we started up and worked on technology and product exploration; as we gradually develop and vary our product lines, we appreciate the platform and corresponding support given in Guangzhou.' Ms. Zhou Dan said, 'As a hi-tech unicorn in Guangzhou, Burning Rock will work hard with glory to play a crucial role in the city's innovation and development and devote to leading in innovation and developing accurate and reliable NGS testing products for the clinical benefit of cancer patients.'

Disclaimer

Burning Rock Biotech Ltd. published this content on 14 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 September 2021 08:11:02 UTC.


© Publicnow 2021
All news about BURNING ROCK BIOTECH LIMITED
11/17Merck KGaA, Darmstadt, Germany and Burning Rock Collaborate on Liquid-biopsy Based CDx ..
AQ
11/16Health Care Stocks Mixed Pre-Bell Tuesday
MT
11/16Burning Rock Biotech Reports Wider Q3 Loss, Higher Revenue
MT
11/16BURNING ROCK BIOTECH : Reports Third Quarter 2021 Financial Results - Form 6-K
PU
11/16Burning Rock Biotech Limited Reports Earnings Results for the Third Quarter and Nine Mo..
CI
11/15Burning Rock Announces 2021 Annual General Meeting to be Held on December 28, 2021
GL
11/15Burning Rock Reports Third Quarter 2021 Financial Results
GL
11/15Burning Rock Biotech Limited Provides Revenue Guidance for the Full Year 2021
CI
11/04Burning Rock Collaborates with IMPACT Therapeutics to Provide Testing Services in Devel..
GL
11/04Burning Rock Collaborates with IMPACT Therapeutics to Provide Testing Services in Devel..
GL
More news
Analyst Recommendations on BURNING ROCK BIOTECH LIMITED
More recommendations
Financials
Sales 2021 500 M 78,4 M 78,4 M
Net income 2021 -395 M -62,0 M -62,0 M
Net cash 2021 1 220 M 191 M 191 M
P/E ratio 2021 -20,1x
Yield 2021 -
Capitalization 7 985 M 1 252 M 1 253 M
EV / Sales 2021 13,5x
EV / Sales 2022 11,0x
Nbr of Employees 938
Free-Float 62,2%
Chart BURNING ROCK BIOTECH LIMITED
Duration : Period :
Burning Rock Biotech Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BURNING ROCK BIOTECH LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 76,38 CNY
Average target price 177,95 CNY
Spread / Average Target 133%
EPS Revisions
Managers and Directors
Yu Sheng Han Chairman & Chief Executive Officer
Leo Li Chief Financial Officer & Director
Zhi Hong Zhang Chief Technology Officer
Shao Kun Chuai Chief Operating Officer & Director
Wendy Hayes Independent Director
Sector and Competitors